Abeona therapeutics® reports full year 2024 financial results, provides pz-cel regulatory update and commercial launch plans

Fda priority review of pz-cel biologics license application (bla) progressing with prescription drug user fee act (pdufa) target action date of april 29, 2025

ABEO Ratings Summary

ABEO Quant Ranking